Charles River Laboratories’ Post

Using a phase-appropriate approach, our recombinant off-the-shelf AAV and LVV viral vectors and plasmids make for more simplified gene therapy development. Empower breakthroughs in your discovery phase and start with the end in mind with a complete concept to cure portfolio through Charles River. Empower Your Research: https://okt.to/2YeDB7

Using a phase-appropriate approach, our recombinant off-the-shelf AAV and LVV viral vectors and plasmids make for more simplified gene therapy development. Empower breakthroughs in your discovery phase and start with the end in mind with a complete concept to cure portfolio through Charles River. Empower Your Research: https://okt.to/gV8F9f

Using a phase-appropriate approach, our recombinant off-the-shelf AAV and LVV viral vectors and plasmids make for more simplified gene therapy development. Empower breakthroughs in your discovery phase and start with the end in mind with a complete concept to cure portfolio through Charles River. Empower Your Research: https://okt.to/gzW4nf

How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/zpnVjP #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody

How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/cGDBjv #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody

How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/8Yfqm3 #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody

Learn a protocol for the isolation of next-generation gene therapy vectors through engineering, barcoding, and screening of Adeno-Associated Virus (AAV) capsid variants by authors Dr. Kleopatra Rapti and colleagues from the University of Heidelberg. Watch on JoVE: https://hubs.ly/Q02ff6GY0

How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/8UhTGW #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody

Cell and gene therapy is a fast-evolving field, and new advances are transforming how we treat some diseases. A panel of expert speakers at our Accelerating Science Forum will discuss the latest developments, opportunities, and challenges in cell and gene therapy, to help biopharma labs accelerate their research. Register for free today. #cellandgenetherapy #biologics #biopharmaceuticals #therapeutics #paneldiscussion #scientificresearch #forum #sciencecommunication

Learn about today’s top challenges in #CellAndGeneTherapy and how to solve them from Johan Hultman at this year’s #ESACT. Explore more about Sartorius cell and gene therapy solutions: https://sar.to/5t6ox #SimplifyingProgress #InThisTogether #AdvancedTherapies #ESACT2024